DarioHealth (DRIO) Shares Outstanding (Weighted Average) (2016 - 2025)

DarioHealth filings provide 14 years of Shares Outstanding (Weighted Average) readings, the most recent being $4.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 62.44% to $4.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 million, a 62.44% increase, with the full-year FY2025 number at $4.0 million, up 62.44% from a year prior.
  • Shares Outstanding (Weighted Average) hit $4.0 million in Q4 2025 for DarioHealth, up from $3.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $48.5 million in Q2 2025 to a low of $2.0 million in Q3 2024.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $22.7 million (2022), compared with a mean of $22.2 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 353.8% in 2021 and later tumbled 92.99% in 2024.
  • DarioHealth's Shares Outstanding (Weighted Average) stood at $16.6 million in 2021, then skyrocketed by 42.45% to $23.6 million in 2022, then increased by 20.04% to $28.4 million in 2023, then plummeted by 91.36% to $2.5 million in 2024, then surged by 62.44% to $4.0 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $4.0 million (Q4 2025), $3.1 million (Q3 2025), and $48.5 million (Q2 2025) per Business Quant data.